These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 14587168)
61. [Therapeutic strategies to improve the outcome of patients with diabetes mellitus and acute coronary syndrome]. Cavallini C G Ital Cardiol (Rome); 2006 Apr; 7(4 Suppl 1):13S-20S. PubMed ID: 16749287 [TBL] [Abstract][Full Text] [Related]
62. An analysis of the Association of Society of Chest Pain Centers Accreditation to American College of Cardiology/American Heart Association non-ST-segment elevation myocardial infarction guideline adherence. Chandra A; Glickman SW; Ou FS; Peacock WF; McCord JK; Cairns CB; Peterson ED; Ohman EM; Gibler WB; Roe MT Ann Emerg Med; 2009 Jul; 54(1):17-25. PubMed ID: 19282062 [TBL] [Abstract][Full Text] [Related]
63. Glycoprotein IIb/IIIa inhibition and long-term benefit: the stuff of dreams? Montalescot G Eur Heart J; 2004 Sep; 25(18):1562-4. PubMed ID: 15351154 [No Abstract] [Full Text] [Related]
66. Reperfusion therapy for acute myocardial infarction: drugs or devices? Is this the right question? Pavlides GS; Cokkinos DV Clin Cardiol; 2004 May; 27(5):254-6. PubMed ID: 15188937 [No Abstract] [Full Text] [Related]
67. [Thrombolytic treatment in acute myocardial infarction]. Røde R Tidsskr Nor Laegeforen; 1989 Feb; 109(4):428-9. PubMed ID: 2645687 [No Abstract] [Full Text] [Related]
68. Reperfusion therapy for acute myocardial infarction. McPherson JA; Gibson RS Emerg Med Clin North Am; 2001 May; 19(2):433-49, xii. PubMed ID: 11373988 [TBL] [Abstract][Full Text] [Related]
72. The general concepts of an equivalence trial, applied to ASSENT-2, a large-scale mortality study comparing two fibrinolytic agents in acute myocardial infarction. Lesaffre E; Bluhmki E; Wang-Clow F; Berioli S; Danays T; Fox NL; Van de Werf F Eur Heart J; 2001 Jun; 22(11):898-902. PubMed ID: 11428813 [No Abstract] [Full Text] [Related]
73. Questions linger in choice of thrombolytics. Berek B Hosp Technol Ser; 1994 Jul; 13(9):1-3. PubMed ID: 10134921 [No Abstract] [Full Text] [Related]
74. Pharmacotherapy during percutaneous coronary intervention in acute myocardial infarction. Rognoni A Cardiovasc Hematol Agents Med Chem; 2013 Jun; 11(2):83. PubMed ID: 22963496 [No Abstract] [Full Text] [Related]
75. [Ischemic heart disease (VII). Determinants of functional recovery after thrombolytic treatment]. Suárez de Lezo J; Pan M; Romero M; Segura J; Sancho M Rev Esp Cardiol; 1988; 41(7):426-36. PubMed ID: 3247503 [No Abstract] [Full Text] [Related]
76. Protection of the myocardium during myocardial infarction: pharmacologic protection during thrombolytic therapy. Willerson JT; Buja LM Am J Cardiol; 1990 May; 65(19):35I-41I. PubMed ID: 2186610 [TBL] [Abstract][Full Text] [Related]